Literature DB >> 9017398

Characterization of maternal and zygotic D-raf proteins: dominant negative effects on Torso signal transduction.

K Radke1, K H Baek, L Ambrosio.   

Abstract

The maternal D-raf serine/threonine kinase acts downstream of Torso (Tor) for specification of cell fates at the embryonic termini. D-raf activity is also required in other signal transduction pathways and consistent with its pleiotropic role, we find accumulation of a 90-kD D-raf protein throughout embryonic development. We also characterize the accumulation of maternal D-raf proteins in 0-2-hr embryos derived from females with germ cells lacking D-raf activity. Accumulation of a 90-kD or truncated mutant D-raf protein is observed for some of these embryos, while others lack the maternal D-raf protein. Then to determine whether rescue of the Tor pathway is influenced by pools of nonfunctional maternal D raf. wild-type D-raf mRNA was injected into embryos that inherit maternal stores of inactive 90-kD of truncated D-raf protein. For embryos lacking the maternal D-raf protein, a high level of terminal rescue is obtained. In contrast, rescue is reduced or not observed for embryos that accumulate mutant maternal D-raf proteins. These findings suggest that mutant forms of D-raf may deplete the embryo of a positive activator and/or form inactive protein complexes that affect rescue of the Tor pathway.

Mesh:

Substances:

Year:  1997        PMID: 9017398      PMCID: PMC1207774     

Source DB:  PubMed          Journal:  Genetics        ISSN: 0016-6731            Impact factor:   4.562


  48 in total

1.  Direct activation of the serine/threonine kinase activity of Raf-1 through tyrosine phosphorylation by the PDGF beta-receptor.

Authors:  D K Morrison; D R Kaplan; J A Escobedo; U R Rapp; T M Roberts; L T Williams
Journal:  Cell       Date:  1989-08-25       Impact factor: 41.582

2.  The Drosophila gene torso encodes a putative receptor tyrosine kinase.

Authors:  F Sprenger; L M Stevens; C Nüsslein-Volhard
Journal:  Nature       Date:  1989-04-06       Impact factor: 49.962

3.  A non-radioactive in situ hybridization method for the localization of specific RNAs in Drosophila embryos reveals translational control of the segmentation gene hunchback.

Authors:  D Tautz; C Pfeifle
Journal:  Chromosoma       Date:  1989-08       Impact factor: 4.316

4.  Signal transduction from membrane to cytoplasm: growth factors and membrane-bound oncogene products increase Raf-1 phosphorylation and associated protein kinase activity.

Authors:  D K Morrison; D R Kaplan; U Rapp; T M Roberts
Journal:  Proc Natl Acad Sci U S A       Date:  1988-12       Impact factor: 11.205

5.  Two gap genes mediate maternal terminal pattern information in Drosophila.

Authors:  D Weigel; G Jürgens; M Klingler; H Jäckle
Journal:  Science       Date:  1990-04-27       Impact factor: 47.728

6.  Localized surface activity of torso, a receptor tyrosine kinase, specifies terminal body pattern in Drosophila.

Authors:  J Casanova; G Struhl
Journal:  Genes Dev       Date:  1989-12       Impact factor: 11.361

7.  The Drosophila gene tailless is expressed at the embryonic termini and is a member of the steroid receptor superfamily.

Authors:  F Pignoni; R M Baldarelli; E Steingrímsson; R J Diaz; A Patapoutian; J R Merriam; J A Lengyel
Journal:  Cell       Date:  1990-07-13       Impact factor: 41.582

8.  A pupal lethal mutation with a paternally influenced maternal effect on embryonic development in Drosophila melanogaster.

Authors:  N Perrimon; L Engstrom; A P Mahowald
Journal:  Dev Biol       Date:  1985-08       Impact factor: 3.582

9.  l(1)pole hole is required maternally for pattern formation in the terminal regions of the embryo.

Authors:  L Ambrosio; A P Mahowald; N Perrimon
Journal:  Development       Date:  1989-05       Impact factor: 6.868

10.  Studies of nuclear and cytoplasmic behaviour during the five mitotic cycles that precede gastrulation in Drosophila embryogenesis.

Authors:  V E Foe; B M Alberts
Journal:  J Cell Sci       Date:  1983-05       Impact factor: 5.285

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.